Literature DB >> 29761090

The Role of Vascular Calcification in Heart Failure and Cognitive Decline.

Hao-Min Cheng1,2,3, Jiun-Jr Wang4, Chen-Huan Chen1,2,3.   

Abstract

Vascular calcification is heterogeneous and triggered by multiple mechanisms. It has been implicated in the development of heart failure with preserved ejection fraction (HFpEF) and cognitive function impairment. Understanding the pathophysiology of vascular calcification may help us improve the management of HFpEF, atherosclerosis, accelerated arterial stiffness, hypertension, and cognitive dysfunction. Currently, there are no effective strategies for treating accelerated arterial stiffness. This may indicate that once arterial stiffness or vascular calcification has developed, it may be less likely to stop the ongoing pathophysiology. Therefore, earlier intervention targeting the probable pathways of vascular calcification may benefit the patients with vascular calcification and related pathological conditions. In this review, we briefly discuss the proposed pathophysiological roles of vascular calcification in the development of heart failure and cognitive decline, the animal models used to study the link between vascular calcification and cardiovascular diseases, and the possible corresponding management strategies.

Entities:  

Keywords:  Arterial stiffness; Cardiovascular disease; Hypertension; Vascular calcification

Year:  2017        PMID: 29761090      PMCID: PMC5939697          DOI: 10.1159/000484941

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  58 in total

1.  Increased aortic stiffness: an unfavorable cardiorenal connection.

Authors:  Gary F Mitchell
Journal:  Hypertension       Date:  2004-01-12       Impact factor: 10.190

2.  Chronic kidney disease: No significant effect of cinacalcet on cardiovascular outcomes in patients undergoing dialysis--EVOLVE results.

Authors:  Ellen F Carney
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

Review 3.  Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease.

Authors:  Pablo A Ureña Torres; Marc De Broe
Journal:  Kidney Int       Date:  2012-03-21       Impact factor: 10.612

4.  Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.

Authors:  Susann Helas; Claudia Goettsch; Michael Schoppet; Ute Zeitz; Ute Hempel; Henning Morawietz; Paul J Kostenuik; Reinhold G Erben; Lorenz C Hofbauer
Journal:  Am J Pathol       Date:  2009-07-09       Impact factor: 4.307

5.  Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients.

Authors:  Léon H G Henskens; Abraham A Kroon; Robert J van Oostenbrugge; Ed H B M Gronenschild; Monique M J J Fuss-Lejeune; Paul A M Hofman; Jan Lodder; Peter W de Leeuw
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

6.  Efficacy of reversal of aortic calcification by chelating agents.

Authors:  Yang Lei; Arjun Grover; Aditi Sinha; Naren Vyavahare
Journal:  Calcif Tissue Int       Date:  2013-11       Impact factor: 4.333

7.  Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

Authors:  Koba A Lomashvili; Marie-Claude Monier-Faugere; Xiaonan Wang; Hartmut H Malluche; W Charles O'Neill
Journal:  Kidney Int       Date:  2009-01-07       Impact factor: 10.612

8.  Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.

Authors:  Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Rachel H Mackey; Eric M McDade; William E Klunk; Howard J Aizenstein; Ann D Cohen; Beth E Snitz; Chester A Mathis; Steven T Dekosky; Oscar L Lopez
Journal:  Neurology       Date:  2013-10-16       Impact factor: 9.910

9.  Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.

Authors:  Wei Ling Lau; Elizabeth M Leaf; Ming Chang Hu; Marc M Takeno; Makoto Kuro-o; Orson W Moe; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2012-08-29       Impact factor: 10.612

Review 10.  Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden.

Authors:  Marijana Tadic; Cesare Cuspidi; Dagmara Hering
Journal:  BMC Cardiovasc Disord       Date:  2016-11-03       Impact factor: 2.298

View more
  8 in total

1.  The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysis.

Authors:  Willian Abraham da Silveira; Esteban Vazquez-Hidalgo; Elesha Bartolotta; Ludivine Renaud; Paul Paolini; Gary Hardiman
Journal:  Pharmacogenomics       Date:  2019-11       Impact factor: 2.533

2.  Association between coronary artery calcification and cognitive function in a Chinese community-based population.

Authors:  Ya-Nan Ma; Wu-Xiang Xie; Zhi-Hui Hou; Yun-Qiang An; Xin-Shuang Ren; Yan-Jun Ma; Cheng-Long Li; Yang-Feng Wu; Bin Lu
Journal:  J Geriatr Cardiol       Date:  2021-07-28       Impact factor: 3.327

3.  Adiponectin inhibits vascular smooth muscle cell calcification induced by beta-glycerophosphate through JAK2/STAT3 signaling pathway.

Authors:  Yan Lu; Yichao Ma; Ruihua Wang; Jing Sun; Beibei Guo; Ruipeng Wei; Yongping Jia
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

Review 4.  Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player.

Authors:  Marian Wesseling; Julius H C de Poel; Saskia C A de Jager
Journal:  ESC Heart Fail       Date:  2020-05-18

5.  Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques.

Authors:  Niki Tombolesi; Raffaele Altara; Gustavo J J da Silva; Cynthia Tannous; Fouad A Zouein; Kåre-Olav Stensløkken; Assunta Morresi; Marco Paolantoni; George W Booz; Alessandro Cataliotti; Paola Sassi
Journal:  Sci Rep       Date:  2022-03-02       Impact factor: 4.379

6.  Propensity for Calcification in Serum Associates With 2-Year Cardiovascular Mortality in Ischemic Heart Failure With Reduced Ejection Fraction.

Authors:  Marija Bojic; Lorenz Koller; Daniel Cejka; Alexander Niessner; Bernhard Bielesz
Journal:  Front Med (Lausanne)       Date:  2021-06-18

Review 7.  Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.

Authors:  Rajasekharreddy Pala; V T Anju; Madhu Dyavaiah; Siddhardha Busi; Surya M Nauli
Journal:  Int J Nanomedicine       Date:  2020-05-27

8.  Abdominal aortic calcification is superior to other arteries calcification in predicting the mortality in peritoneal dialysis patients - a 8 years cohort study.

Authors:  Qingyu Niu; Huiping Zhao; Bei Wu; Shihming Tsai; Jian Wu; Meng Zhang; Lixia Lu; Jie Qiao; Chuncui Men; Li Zuo; Mei Wang
Journal:  BMC Nephrol       Date:  2019-12-02       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.